Cargando…
COT-12 Clinical feature of end-stage glioblastomas
Glioblastoma is the most common and most aggressive primary brain tumor. Even with optimal treatment, tumors repeatedly recur and grow, eventually invading the entire brain. Few studies have evaluated the pathogenesis and pathophysiology of terminal glioblastoma. In this study, we describe the patho...
Autores principales: | Saito, Norihiko, Hirai, Nozomi, Kushida, Naoki, Sato, Sho, Hiramoto, Yu, Fujita, Satoshi, Nakayama, Haruo, Hayashi, Morito, Ito, Keisuke, Iwabuchi, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648246/ http://dx.doi.org/10.1093/noajnl/vdab159.116 |
Ejemplares similares
-
COT-20 Clinical experience with tumor-treating fields therapy for newly diagnosed glioblastoma
por: Saito, Norihiko, et al.
Publicado: (2020) -
NQPC-15 DEVELOPMENT OF BRAIN TUMOR SURVIVORSHIP PROGRAM
por: Saito, Norihiko, et al.
Publicado: (2022) -
Genetic and Lineage Classification of Glioma-Initiating Cells Identifies a Clinically Relevant Glioblastoma Model
por: Saito, Norihiko, et al.
Publicado: (2019) -
The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma
por: Saito, Norihiko, et al.
Publicado: (2019) -
CBMS-03 PHOSPHORYLATION STATE OF OLIG2 REGULATES PROLIFERATION OF GLIOMA STEM CELLS
por: Saito, Norihiko, et al.
Publicado: (2019)